Human germline editing is an ethical imperative to sustain genetic health
RUSSELL POWELL Boston University, Boston, Massachusetts 2015 In Genes We Trust: Germline Engineering, Eugenics, and the Future of the Human Genome, USA Journal of Medicine and Philosophy 40 (6):669-695 (2015) https://philpapers.org/rec/POWIGW
In this article, I explore some of the evolutionary and social risks that attend the other side of the risk equation: namely, the undesirable consequences that are likely to flow from our failure to intervene in the human germline. I argue that even if we do not have moral reasons to genetically “enhance” our children relative to the current status quo of normality (for arguments that we do, see, e.g., Savulescu, 2001; Bostrom and Ord, 2006; Harris, 2007; Savulescu and Persson, 2008; Buchanan, 2011; Powell and Buchanan, 2011), germline intervention still emerges as a pro tanto moral imperative so long as we have good reason to sustain the levels of genetic health that we presently enjoy for future generations—a goal that should appeal to bioliberals, biomoderates, and bioconservatives alike. My aim is to show that merely preserving important genetic and phenotypic aspects of the human species—and perhaps even human dignity—will require that we overcome the remaining technical obstacles and make germline genetic therapies legal and widely available to healthcare consumers.